Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study examined the effects of omega-3 fatty acids as an adjunct to nonsurgical periodontal therapy in periodontitis patients with type II diabetes, finding significant improvements in various clinical parameters.
This study evaluated the effectiveness of scalable diabetes self-management education and support models in adults with Type 2 Diabetes. Results showed no significant changes in key health outcomes.
The FLOW trial investigated the effects of semaglutide on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease, revealing significant reductions in cardiovascular death, myocardial infarction, and stroke.
This study evaluated the effects of sitagliptin plus metformin therapy on metabolic profiles in patients with type 2 diabetes and NAFLD, finding significant improvements in various metabolic markers.
This study investigated the impact of 24-week Taichi training on pulmonary diffusion capacity and glycemic control in patients with Type 2 Diabetes Mellitus, finding significant improvements in several health markers.
This study evaluated the impact of remote insulin dose adjustment using continuous glucose monitoring (CGM) on glucose control in nursing home residents with type 2 diabetes (T2D). The intervention group showed significant improvements in glucose metrics compared to standard care.
This study evaluated a text messaging-based lifestyle support program for women with gestational diabetes. Results showed no significant differences in key health outcomes compared to a control group.
This study investigated the effects of ultrasound-guided stellate ganglion pulsed radiofrequency therapy on painful diabetic peripheral neuropathy in type 2 diabetes patients, finding significant postoperative improvements in pain and quality of life.
This study investigated the effects of vitamin D supplementation on inflammatory factors in patients with type 2 diabetes, finding significant reductions in certain inflammatory markers.
The AWARD-11 trial compared the effects of Dulaglutide 3.0 mg and 4.5 mg to 1.5 mg on body weight in patients with type 2 diabetes, finding significant weight reductions.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
